News

NABR Responds to IUCN's Endangered Status for Macaques

NABR Responds to IUCN's Endangered Status for Macaques

NABR Comments on IUCN's Decision

The National Association for Biomedical Research (NABR) is addressing the recent decision by the International Union for Conservation of Nature (IUCN) to maintain the 'Endangered' status for long-tailed macaques, scientifically known as Macaca fascicularis. This determination sparked a strong response among researchers and scientists due to ongoing debates about the validity of such classifications.

Scientific Concerns About IUCN's Determination

The IUCN's recent decision follows a petition by NABR challenging their status findings. According to NABR, the claims made by the IUCN are largely based on studies, particularly those conducted by Hansen and colleagues, which misinterpret existing data concerning the long-tailed macaque population. The organization asserts that this misrepresentation could misguide conservation efforts and affect biomedical research significantly.

NABR's Petition for Review

In its petition, NABR highlighted critical concerns regarding the scientific basis for the IUCN's findings. They argued that the data used to support the endangered classification of long-tailed macaques does not accurately reflect current scientific literature, calling into question whether these claims are robust enough to warrant such a significant conservation status.

Conflicts of Interest Raised

Another petition from Dr. Hank Jenkins has emerged, which suggests possible conflicts of interest among the authors of studies relied upon by the IUCN. While it remains uncertain if these conflicts exist, the call for transparency indicates a broader concern regarding the integrity of data used in conservation decision-making.

U.S. Fish and Wildlife Service's Rejection of Endangered Listing

In an independent move, the U.S. Fish and Wildlife Service recently rejected a petition filed by advocacy groups aimed at listing long-tailed macaques under the Endangered Species Act (ESA). The Service emphasized that the petition failed to deliver credible evidence regarding threats to the macaque populations, which is central to defining a species as endangered.

Research and Development Contributions

Long-tailed macaques play a pivotal role in biomedical research due to their genetic and physiological similarities to humans. Their significant application in developing various medications, including crucial drugs for cancer treatment and vaccines, showcases their essential contribution to public health. According to a recent review by the National Institutes of Health (NIH), long-tailed macaques are indispensable in advancing medical research initiatives.

Advocacy for Scientific Objectivity

Matthew R. Bailey, president of NABR, expressed disappointment at the IUCN's apparent disregard for scientific evidence indicating the long-tailed macaques are not endangered. Notably, it's recognized that this species is prevalent in several regions to the extent of being referred to as invasive in some countries, highlighting a contradiction between its status as endangered and its classification as an invasive species.

The Impact of Misinformation

Bailey further criticized the influence of animal rights activists on policy decisions regarding the long-tailed macaque, arguing that their efforts distort the scientific reality surrounding the species. The implications of labeling such a species as endangered, when substantial evidence suggests otherwise, may have detrimental effects on future biomedical research and development efforts.

Calls for Education and Transparency

NABR is committed to educating policymakers and the general public regarding these issues to ensure that decisions affecting biomedicine are grounded in factual scientific evidence rather than unsubstantiated claims. It is essential for organizations like the IUCN to base their conservation statuses on accurate data to protect both public health and scientific integrity.

Frequently Asked Questions

What is NABR?

NABR, or the National Association for Biomedical Research, is a non-profit organization that advocates for the humane use of animals in biomedical research, education, and testing.

Why did NABR challenge the IUCN's decision?

NABR challenged the IUCN's decision because they believe the underlying science is misrepresented and insufficient to justify the 'Endangered' status for long-tailed macaques.

How does the IUCN determine endangered status?

The IUCN evaluates species based on available scientific data concerning their populations, habitats, and threats to their survival, but NABR argues this process can sometimes be flawed.

What role do long-tailed macaques play in biomedical research?

These monkeys are widely used in biomedical research, contributing to significant advancements in various medical fields, including vaccine development and cancer research.

How can the public get involved with NABR?

The public can support NABR by staying informed and advocating for sound public policy related to animal research, as well as participating in discussions regarding conservation efforts based on scientific evidence.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 143

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 132

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 150

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 53

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
55 Broad Street's New Face: A $500M Revamp with RXR

Updated Category News Views 189

Recapitalization: Changing the Game for 55 Broad Street Here we are again, watching yet another iconic Manhattan building redefine itself. This time, it's 55 Broad Street's turn, as Silverstein, MetroLoft, and RXR shake things up. Newmark Group, Inc. (NASDAQ: NMRK), the fiery real estate power player, orchestrated a dynamic transaction involving a $305 million financing...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 107

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading

Top 5 Most Recently Viewed Articles

Padlock Euro Storage Fund I Unveils Fourth-Quarter Distributions

Updated Category News Views 171

Padlock Euro Storage Fund I Distributions for Q4 2024 Padlock Euro Storage Fund I has recently shared good news for its unitholders regarding the cash distribution for the fourth quarter of the calendar year. The board of Trustees has officially approved these distributions, which reflect the Trust’s performance and commitment to its investors. Distribution Details The...

Continue Reading
Deer Park Road Seizes Opportunities Amid Commercial Real Estate Shift

Updated Category News Views 264

Deer Park Road's Strategic Focus on the CRE Market Deer Park Road Management Company, with a robust portfolio of $2.8 billion in alternative asset management, is navigating the turbulent waters of the commercial real estate (CRE) market. While challenges persist, especially in the Commercial Mortgage-Backed Securities (CMBS) sector, the firm sees compelling opportunities...

Continue Reading
MCB Real Estate's Rejection of Whitestone Offer Sparks Debate

Updated Category News Views 76

MCB Real Estate's Proposal Overview MCB Real Estate, a well-known developer in the commercial real estate sector, has made headlines recently with its acquisition proposal for Whitestone REIT. The proposed buyout included a cash offer of $15.00 per share, aimed at delivering a substantial premium to shareholders. MCB highlighted that this offer represented a 14.5%...

Continue Reading
Year-End Cash Dividend Announced for Mexico Equity Fund

Updated Category News Views 111

Year-End Cash Dividend Announced for Mexico Equity Fund The Mexico Equity and Income Fund, Inc. has recently set an exciting precedent for its shareholders by declaring a year-end cash dividend. This decision, made by the Fund’s Board of Directors, reflects a commitment to delivering value and returns to its investors. Details of the Cash Dividend The announced dividend...

Continue Reading
Emerging Trends in Altcoins: Navigating the Crypto Landscape

Updated Category News Views 168

Rising Speculation in Altcoins: An Overview Recent activities in the altcoin sector indicate a significant increase in leveraged positions, particularly with Ethereum and other notable altcoins. This surge has raised eyebrows in the crypto community, as analysts caution about potential fragility within the market, even as Bitcoin shows signs of relative stability....

Continue Reading